Chronic Rapamycin Treatment or Lack ofS6K1does Not Reduce Ribosome Activity in Vivo

Cell Cycle - United States
doi 10.4161/cc.25512
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Enhanced Antitumor Activity of 3-Bromopyruvate in Combination With Rapamycin in Vivo and in Vitro

Cancer Prevention Research
MedicineCancer ResearchOncology
2015English

Cdc5 Blocks in Vivo Rad53 Activity, but Not in Situ Activity (ISA)

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Review: Brief Interventions Reduce Drinking in Patients Not Seeking Treatment

Evidence-Based Medicine
Medicine
2002English

Kinetic Analysis of Pre-Ribosome Structure in Vivo

RNA
Molecular Biology
2012English

Chronic Hepatitis C in PWIDs, Treat or Not to Treat

Journal of Liver Research, Disorders & Therapy
2017English

Periodontal Treatment Does Not Result in Detectable Platelet Activation in Vivo

Clinical Oral Investigations
Dentistry
2019English

Chronic Endothelin-1 Treatment Leads to Insulin Resistance in Vivo

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Vitamin Supplements Do Not Reduce Incidence of Cancer or Heart Disease

BMJ
2003English

Rapamycin – “One Size Does Not Fit All”

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy